Volume 4, Issue 3: Advances in Treating Hard-to-Treat Hepatitis C: Highlights from the American Association for the Study of Liver Diseases (AASLD) Meeting November 2015

e-Viral Hepatitis Review is a monthly CE series for nurses, nurse practitioners, and others involved in the care of patients with HepatitisIt provides updates on the latest research, best practices, and issues currently under debate, as well as a concise review of relevant journal literature.

(Volume 4, Issue 3)

Target Audience

Nurses and health care professionals involved in the care of patients with Hepatitis.

Learning Objectives

After participating in this activity, the participant will demonstrate the ability to: 

  • Describe ongoing research into new therapies for patients with HCV genotype 3
  • Evaluate the development of new agents and agent combinations to better manage hard-to-treat patients with HCV.
  • Summarize real-world use of DAA therapies to manage HCV.
Additional information
Contact email: 
Course summary
Available credit: 
  • 1.00 ANCC
  • 1.00 Attendance
Course opens: 
12/29/2015
Course expires: 
12/28/2017
Cost:
$0.00
Mark S. Sulkowski, MD
Professor of Medicine
Medical Director, Viral Hepatitis Center
Divisions of Infectious Diseases and Gastroenterology/Hepatology
Johns Hopkins University School of Medicine
Baltimore, Maryland
 
Stephanie Petrou Binder, MD
Medical Writer
Berlin, Germany

Available Credit

  • 1.00 ANCC
  • 1.00 Attendance

Accreditation Period

Course opens: 
12/29/2015
Course expires: 
12/28/2017

Price

Cost:
$0.00
Please login or register to take this course.

Required Hardware/software

Make sure your Adobe flash is updated by clicking HERE